The FDA-approved imaging agent for detecting coronary artery disease gained Medicare and Medicaid coverage starting April 1.
Not to be confused with creatures that we keep as pets, the similarly-named PET scan is an imaging modality used in the medical field.
TLX007-CDx was approved by the FDA for PSMA-PET scanning in adult male patients with prostate cancer with suspected ...
The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 ...
According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.
Dozens of people gathered in St. Albans on Thursday to see the unveiling of the new microchip scanning station at the St.
Medical Device Network on MSN9d
Telix’s prostate cancer imaging agent approved in BrazilBrazilian Health Regulatory Agency (ANVISA) has granted approval for Telix Pharmaceuticals’ Illuccix, a prostate cancer ...
TLX007-CDx is a cold kit designed for the preparation of PSMA-targeted PET imaging for prostate cancer. It leverages ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback